Skip to main content

Pacientes Normotensos con Apnea del Sueño: Impacto Diferencial del Tratamiento con CPAP según el Patrón Circadiano de Presión Arterial. Ensayo Clínico Aleatorizado. Estudio MOISÉS.

PI22/00636

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i en Salud
Call year 2022
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre INSTITUTO INV. BIOMEDICA DE LLEIDA. FUNDACION DR. PIFARRE (IRBLLEIDA)
Execution centre INSTITUTO INV. BIOMEDICA DE LLEIDA. FUNDACION DR. PIFARRE (IRBLLEIDA)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Hypoxic burden to guide CPAP treatment allocation in patients with obstructive sleep apnoea, a post hoc study of the ISAACC trial

  • Pinilla, Lucía|||0000-0003-2825-4056
  • Esmaeili, Neda
  • Labarca, Gonzalo|||0000-0002-0069-3420
  • Martínez García, Miguel Ángel|||0000-0002-7321-1891
  • Torres, Gerard|||0000-0002-1417-7320
  • Gracia-Lavedan, Esther
  • Mínguez, Olga
  • Martínez López, Dolores
  • Abad Capa, Jorge|||0000-0002-8129-7859
  • Masdeu, Maria José
  • Mediano, Olga|||0000-0001-7824-1523
  • Muñoz-Batet, Carmen|||0000-0002-4150-8834
  • Cabriada-Nuño, Valentín|||0000-0003-1124-7108
  • Duran-Cantolla, Joaquin|||0000-0001-8172-9415
  • Mayos, Merce|||0000-0003-3972-3671
  • Coloma Navarro, Ramón|||0000-0002-4280-415X
  • Montserrat, Josep María
  • De la Peña, Mónica|||0000-0003-3276-776X
  • Hu, Wen-Hsin
  • Messineo, Ludovico
  • Sehhati, Mohammadreza
  • Wellman, Andrew
  • Redline, Susan
  • Sands, Scott
  • Barbé, Ferran|||0000-0002-2340-8928
  • Sánchez de la Torre, Manuel|||0000-0002-5695-348X
  • Azarbarzin, Ali|||0000-0002-4986-4753
Hypoxic burden (HB) has emerged as a strong predictor of cardiovascular risk in obstructive sleep apnoea (OSA). We aimed to assess the potential of HB to predict the cardiovascular benefit of treating OSA with continuous positive airway pressure (CPAP). This was a post hoc analysis of the ISAACC trial (: NCT01335087) including non-sleepy patients with acute coronary syndrome (ACS) diagnosed with OSA (apnoea-hypopnoea index ≥15 events·h -1) by respiratory polygraphy. Patients were randomised to CPAP or usual care and followed for a minimum of 1 year. HB was calculated as the total area under all automatically identified desaturations divided by total sleep time. Patients were categorised as having high or low baseline HB according to the median value (73.1%min·h -1). Multivariable Cox regression models were used to assess whether the effect of CPAP on the incidence of cardiovascular outcomes was dependent on the baseline HB level. The population (362 patients assigned to CPAP and 365 patients assigned to usual care) was middle-aged (mean age 59.7 years), overweight/obese and mostly male (84.5%). A significant interaction was found between the treatment arm and the HB categories. In the high HB group, CPAP treatment was associated with a significant reduction in the incidence of cardiovascular events (HR 0.57, 95% CI 0.34-0.96). In the low HB group, CPAP-treated patients exhibited a trend toward a higher risk of cardiovascular outcomes than those receiving usual care (HR 1.33, 95% CI 0.79-2.25). The differential effect of the treatment depending on the baseline HB level followed a dose-response relationship. In non-sleepy ACS patients with OSA, high HB levels were associated with a long-term protective effect of CPAP on cardiovascular prognosis.